HemoSphere Alta Study

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

October 31, 2026

Conditions
Hemodynamic Instability
Interventions
DEVICE

HemoSphere Alta Monitor, Swan-Ganz IQ pulmonary arterial catheter, ForeSight IQ Large sensor, and Acumen IQ sensor

Subjects with planned monitoring with a pulmonary artery catheter in the operating room, will be monitored with the above listed devices.

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY